Dr. Gordon Chiu
is an execution driven businessman with more than 15 years of combined domestic and international experience in biomedical, chemical, cosmetic, medical and technology industries.
He has been invited to serve on the board of public and private companies and to provide vital advice to the board while increasing overall shareholder value.
background and experience has led to numerous accomplishments across fields, including: Alzheimer research, breast cancer research, dermatology, drug addictions research, green technology and antimicrobial research.
He started his career as a research scientist at Pfizer Inc and Merck & Co.
healthcare and marketing experience includes strong links to both Wall Street and Asia.
educational background began with a B.S. degree in Chemistry from Rensselaer Polytechnic Institute with a summa cum laude.
He graduated with an M.S. degree in Chemistry from Seton Hall University with high honors.
Additionally, Dr. Chiu was accepted as an MD/PhD candidate under the National Institutes of Health's Medical Scientist Training Program for four years at the Mount Sinai School of Medicine where he also researched, developed, consulted and advised the Department of Dermatology's Dr. Huachen Wei in skin cancer research.
Seeing the opportunity to impact foreign policies in healthcare, he transferred his credentials to University of Bridgeport School of Naturopathic Medicine where he received his doctorate in naturopathic medicine.
With this unique background, he
has investigated the validity of foreign treatments and their success level for public health.
has also been chosen to serve an advisory role in the identification of low cost solutions (i.e. non-invasive diagnostic equipment) for emerging countries that cannot afford to maintain armies of physicians across numerous sub-specialties.
developed and owns methodologies called directed combinatorial algorithmic libraries (D.C.A.L.) that are used in various commercial applications, composition development and research.